ArticleAdvanced science (Weinheim, Baden-Wurttemberg, Germany)2026
A Soft Robotic Model for Simulating Heart Valve Disease and Cardiac Interventions.
Article in Advanced science (Weinheim, Baden-Wurttemberg, Germany), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Compliance modulation of a soft robotic atrioventricular model of heart failure with preserved ejection fraction.Nature communications · 2026Article
- Methodological development of a pneumatic artificial muscle-driven left ventricular simulator using interpretive structural modeling.PloS one · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
15 authors.
Funding
Abstract
The heart is a dynamic, multisystem organ whose motion is dictated by a complex but organized muscular architecture. Each component is vital to its performance, with the valves being especially critical for ensuring pumping efficiency, yet they are among the most common sites of pathology. Treatment of heart disease is being delivered via minimally invasive procedures to improve patient outcomes and experience. The development of new surgical tools and procedures would greatly benefit from a stable, controllable, and biomimetic simulation platform that accurately replicates the heart's biomechanics and hemodynamics, yet no such system exists. This work introduces a fully synthetic, soft robotic left heart simulator capable of replicating the complex motions of native heart. Its advanced fabrication process is programmable, enabling both patient- and disease-specific cardiac geometries, structures, and valves. The simulator is compatible with clinical echocardiographic imaging, enabling identification of various valvular pathologies based on clinical diagnostic criteria. Its utility is further demonstrated through the evaluation of a new soft robotic cardiac catheter with in-situ contact force sensing and feedforward, data-driven control system. With controllable artificial musculature and customizable internal cardiac structures and geometry, the simulator offers a robust platform for investigating cardiac disease and assessing emerging therapeutic technologies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.